Structural investigation on the intrinsically disordered N-terminal region of HPV16 E7 protein
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Human papillomavirus (HPV) is the major cause of cervical cancer, a deadly threat to millions of females. The early oncogene product (E7) of the high-risk HPV16 is the primary agent associated with HPV-related cervical cancers. In order to understand how E7 contributes to the transforming activity, we investigated the structural features of the flexible N-terminal region (46 residues) of E7 by carrying out N-15 heteronuclear NMR experiments and replica exchange molecular dynamics simulations. Several NMR parameters as well as simulation ensemble structures indicate that this intrinsically disordered region of E7 contains two transient (10-20% populated) helical pre-structured motifs that overlap with important target binding moieties such as an E2F-mimic motif and a pRb-binding LXCXE segment. Presence of such target-binding motifs in HPV16 E7 provides a reasonable explanation for its promiscuous target-binding behavior associated with its transforming activity.
Abstract
Human papillomavirus (HPV) is the major cause of cervical cancer, a deadly threat to millions of females. The early oncogene product (E7) of the high-risk HPV16 is the primary agent associated with HPV-related cervical cancers. In order to understand how E7 contributes to the transforming activity, we investigated the structural features of the flexible N-terminal region (46 residues) of E7 by carrying out N-15 heteronuclear NMR experiments and replica exchange molecular dynamics simulations. Several NMR parameters as well as simulation ensemble structures indicate that this intrinsically disordered region of E7 contains two transient (10-20% populated) helical pre-structured motifs that overlap with important target binding moieties such as an E2F-mimic motif and a pRb-binding LXCXE segment. Presence of such target-binding motifs in HPV16 E7 provides a reasonable explanation for its promiscuous target-binding behavior associated with its transforming activity.
참고문헌 (39)
- Frazer I, "Vaccines for papillomavirus infection", Virus Res, 89, pp.271~274 (2002)
- Roman A, "The papillomavirus E7proteins", Virology, 445, pp.138~168 (2013)
- McLaughlin-Drubin ME, "Cancer associated human papillomaviruses", Curr Opin Virol, 2, pp.459~466 (2012)
- Chemes LB, "Evolution of linear motifs within the papillomavirus E7 oncoprotein", J Mol Biol, 422, pp.336~346 (2012)
- Munger K, "Biological activities and molecular targets of the human papillomavirus E7 oncoprotein", Oncogene, 20, pp.7888~7898 (2001)
- 이시형, "Structural Characterization of an Intrinsically Unfolded Mini-HBX Protein from Hepatitis B Vi-rus", Molecules and Cells, 34(2), pp.165~169 (2012), 한국분자세포생물학회[DOI]
- Garcia-Alai MM, "The N-terminal module of HPV16 E7 is an intrinsically disordered domain that confers conformational and recognition plasticity to the oncoprotein", Biochemistry, 46, pp.10405~10412 (2007)
- Liu X, "Structure of the human papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor", J Biol Chem, 281, pp.578~586 (2005)
- Ohlenschlager O, "Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7", Oncogene, 25, pp.5953~5959 (2006)
- Todorovic B, "Systematic analysis of the amino acid residues of human papillomavirus type 16 E7 conserved region 3 involved in dimerization and transformation", J Virol, 85, pp.10048~10057 (2011)
- Alonso LG, "High-risk(HPV16)human papillomavirus E7 oncoprotein is highly stable and extended, with conformational transitions that could explain its multiple cellular binding partners", Biochemistry, 41, pp.10510~10518 (2002)
- Clements A, "Oligomerization properties of the viral oncoproteins adenovirus E1A and human papillomavirus E7 and their complexes with the retinoblastoma protein", Biochemistry, 39, pp.16033~16045 (2000)
- Alonso LG, "The HPV16 E7 viral oncoprotein self-assembles into defined spherical oligomers", Biochemistry, 43, pp.3310~3317 (2004)
- Dunker AK, "What’s in a name? Why these proteins are intrinsically disordered", Intrinsically Disordered Proteins, 1, pp.e24157~ (2013)
- Lee S-H, "Understanding pre-structured motifs(PreSMos)in intrinsically unfolded proteins", Curr Protein Pept Sci, 13, pp.34~54 (2012)
- Uversky VN, "Intrinsically disordered proteins in human diseases:Introducing the D2 concept", Ann Rev Biophys, 37, pp.215~246 (2008)
- James TL, "Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform", Proc Natl Acad Sci U S A, 94, pp.10086~10091 (1997)
- Xue B, "Structural disorder in viral proteins", Chem Rev, 114, pp.6880~6911 (2014)
- Radhakrishnan I, "Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: A model for activator:coactivator interactions", Cell, 91, pp.741~752 (1997)
- Fletcher CM, "The interaction of eIF4E with 4E-BP1 is an induced fit to a completely disordered protein", Protein Sci, 7, pp.1639~1642 (1998)
- De Guzman RN, "CBP", p300 TAZ1 domain forms a structured scaffold for ligand binding, 2005, pp.44, 490~497
- Di Lello P, "Structure of the Tfb1", p53 complex: Insights into the interaction between the p62, Mol Cell, pp.2006, 22[DOI]
- Rowell JP, "HMGB1-facilitated p53 DNA binding occurs via HMG-Box", p53 transactivation domain interaction, regulated by the acidic tail, 2012, pp.20, 2014~2024
- Ha J-H, "Dual-site interactions of p53 protein transactivation domain with anti-apoptotic Bcl-2 family proteins reveal a highly convergent mechanism of divergent p53 pathways", J Biol Chem, 288, pp.7387~7398 (2013)
- Lee CW, "Structure of the p53 transactivation domain in complex with the nuclear coactivator binding domain of CBP", Biochemistry, 49, pp.9964~9971 (2010)
- Bochkareva E, "Single-stranded DNA mimicry in the p53 transactivation domain interaction with replication protein A", Proc Natl Acad Sci U S A, 102, pp.15412~15417 (2005)
- Lee H, "Local structural elements in the mostly unstructured transcriptional activation domain of human p53", J Biol Chem, 275, pp.29426~29432 (2000)
- Chi S-W, "Structural details on mdm2-p53 interaction", J Biol Chem, 280, pp.38795~38802 (2005)
- Noval MG, "Conformational dissection of a viral intrinsically disordered domain involved in cellular transformation", PLoS One, 8, pp.e72760~ (2013)
- Nicolau-Junior N, "Modeling and molecular dynamics of the intrinsically disordered e7proteins from high-and low-risk types of human papillomavirus", J Mol Model, 19, pp.4025~4037 (2013)
- Marsh JA, "Sensitivity of secondary structure propensities to sequence differences between α- and γ-synuclein: Implications for fibrillation", Protein Sci, 15, pp.2795~2804 (2006)
- O'Hare P, "Structural studies of the acidic transactivation domain of the Vmw65 protein of herpes simplex virus using 1H NMR", Biochemistry, 31, pp.4150~4156 (1992)
- Dahlman-Wright K, "Structural characterization of a minimal functional transactivation domain from the human glucocorticoid receptor", Proc Natl Acad Sci U S A, 92, pp.1699~1703 (1995)
- Neal S, "Rapid and accurate calculation of protein 1H, 13C and 15N chemical shifts", J Biomol NMR, 26, pp.215~240 (2003)
- Kim D-H, "A pre-structured helix in the intrinsically disordered 4EBP1", Mol BioSyst, 11, pp.366~369 (2015)
- Borcherds W, "Disorder and residual helicity alter p53-Mdm2 binding affinity and signaling in cells", Nat Chem Biol, 10, pp.1000~1002 (2014)
- Schneider R, "Towards a robust description of intrinsic protein disorder using nuclear magnetic resonance spectroscopy", Mol Biosyst, 8, pp.58~68 (2012)
- Iesmantavicius V, "Helical propensity in an intrinsically disordered protein accelerates ligand binding", Angew Chem Int Ed, 53, pp.1548~1551 (2014)
- Csizmók V, "A novel two-dimensional electrophoresis technique for the identification of intrinsically unstructured proteins", Mol Cell Proteomics, 5, pp.265~273 (2006)